Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 150.61M | € 360.90M | € 181.66M | € 421.22M | € 252.78M |
Total Assets | € 3.07B | € 3.01B | € 2.44B | € 2.50B | € 2.43B |
Total Debt | € 876.59M | € 945.16M | € 683.44M | € 816.84M | € 918.89M |
Net Debt | € 725.98M | € 584.26M | € 501.78M | € 395.63M | € 666.11M |
Total Liabilities | € 1.72B | € 1.69B | € 1.15B | € 1.22B | € 1.33B |
Stockholders Equity | € 1.30B | € 1.27B | € 1.21B | € 1.20B | € 1.03B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |